Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mixed connective tissue disease.

R Kasukawa1

  • 1Department of Internal Medicine II, Fukushima Medical University School of Medicine, Hikarigaoka.

Internal Medicine (Tokyo, Japan)
|July 9, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasonographic evaluation of knee joint synovitis in two patients with palindromic rheumatism.

Modern rheumatology·2014
Same author

Ultrasonographic evaluation of synovial effusion and synovial proliferation pattern in the knee joints of patients with rheumatoid arthritis.

Modern rheumatology·2014
Same author

Usefulness of endoscopic ultrasonographic analysis of variceal hemodynamics for the treatment of esophageal varices.

Fukushima journal of medical science·2002
Same author

A patient with Wegener's granulomatosis with initial clinical presentations of Henoch-Schönlein purpura.

Internal medicine (Tokyo, Japan)·2001
Same author

An ancient lectin-dependent complement system in an ascidian: novel lectin isolated from the plasma of the solitary ascidian, Halocynthia roretzi.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Autoantibodies of sera from patients with primary biliary cirrhosis recognize the alpha subunit of the decarboxylase component of human branched-chain 2-oxo acid dehydrogenase complex.

Journal of hepatology·2001
Same journal

A Possible Case of Drug-induced ANCA-associated Vasculitis Associated with Mirabegron.

Internal medicine (Tokyo, Japan)·2026
Same journal

Microangiopathic Hemolytic Anemia Due to Disseminated Carcinomatosis of the Bone Marrow in Esophageal Adenocarcinoma.

Internal medicine (Tokyo, Japan)·2026
Same journal

Recurrent Sigmoid Diverticulitis Managed with Adjunctive Daiobotanpito: A Case Report.

Internal medicine (Tokyo, Japan)·2026
Same journal

Tracheobronchial mucormycosis.

Internal medicine (Tokyo, Japan)·2026
Same journal

A Case of Transient ACTH and Cortisol Suppression Caused by Dexamethasone Mouthwash during Immune Checkpoint Inhibitor Treatment.

Internal medicine (Tokyo, Japan)·2026
Same journal

Acute Spinal Calcium Pyrophosphate Dehydrate Deposition Disease.

Internal medicine (Tokyo, Japan)·2026
See all related articles

Mixed connective tissue disease (MCTD) is a distinct entity, characterized by high-titer anti-U1snRNP antibodies, HLA-DR4 association, and pulmonary hypertension as a cause of death.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Mixed connective tissue disease (MCTD) has been described since 1972.
  • Despite criticisms, its recognition as a distinct entity persists in medical literature.

Purpose of the Study:

  • To reinforce the argument for Mixed Connective Tissue Disease (MCTD) as a distinct disease entity.
  • To highlight key diagnostic and prognostic features of MCTD.

Main Methods:

  • Literature review and synthesis of characteristic features.
  • Analysis of diagnostic markers and clinical outcomes.

Main Results:

  • High titers of anti-U1snRNP antibodies are a hallmark of MCTD.
  • Increased frequency of HLA-DR4 in leukocytes is associated with MCTD.

Related Experiment Videos

  • Pulmonary hypertension is a significant cause of mortality in MCTD patients.

    • Conclusions:

    • The persistent citation and specific clinical features support MCTD's classification as a distinct disease.
    • Identifying anti-U1snRNP antibodies, HLA-DR4, and monitoring for pulmonary hypertension are crucial for MCTD management.